Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Non-Adherence Costs Manufacturers Billions Of Dollars In Revenues – Study

This article was originally published in The Pink Sheet Daily

Executive Summary

Capgemini’s calculations of potential pharmaceutical revenues if patients were fully compliant with their drug therapy regimens suggest revenues in the U.S. would be nearly 60% higher. But even small changes have sizeable revenue impact.

You may also be interested in...



Medication Adherence: A Positive Story You Are Not Hearing

Pharmaceutical companies are spending more to help patients adhere to their therapeutic regimens – an almost universally recognized way to improve health outcomes and pharma’s bottom line. But an unclear legal and regulatory climate and poor understanding of the adherence problems it is trying to solve means industry isn’t trumpeting what could be one of its best health care value arguments.

Medication Adherence Budgets Rising At Pharma Firms, Report Says, But Impact Still Hard To Calculate

Pharmaceutical companies are investing more money into medication adherence programs, but measuring the success of these programs remains a challenge. Consultants are recommending building adherence plans into the development of a drug, with an emphasis on understanding patients’ approaches to compliance.

Most Common Reason For Poor Rx Adherence: “I Forgot” – NCPA

A study conducted for the National Community Pharmacists Association assigns chronic medication users report card grades based on rates of different non-adherent behaviors and describes the most common reasons along with some possible remedies.

Related Content

Topics

UsernamePublicRestriction

Register

PS073562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel